AAAAAA
Results: 1-25/31
Authors:
KAY NE
LEONG T
BONE N
KYLE RA
GREIPP PR
VANNESS B
OKEN MM
Citation: Ne. Kay et al., T-HELPER PHENOTYPES IN THE BLOOD OF MYELOMA PATIENTS ON ECOG PHASE-III TRIALS E9486 E3A93/, British Journal of Haematology, 100(3), 1998, pp. 459-463
Authors:
GREIPP PR
LEONG T
BENNETT JM
GAILLARD JP
KLEIN B
STEWART JA
OKEN MM
KAY NE
VANNESS B
KYLE RA
Citation: Pr. Greipp et al., PLASMABLASTIC MORPHOLOGY - AN INDEPENDENT PROGNOSTIC FACTOR WITH CLINICAL AND LABORATORY CORRELATES - EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) MYELOMA TRIAL E9486 REPORT BY THE ECOG MYELOMA LABORATORY GROUP, Blood, 91(7), 1998, pp. 2501-2507
Authors:
TAO ML
BARNES PD
BILLETT AL
LEONG T
SHRIEVE DC
SCOTT RM
TARBELL NJ
Citation: Ml. Tao et al., CHILDHOOD OPTIC CHIASM GLIOMAS - RADIOGRAPHIC RESPONSE FOLLOWING RADIOTHERAPY AND LONG-TERM CLINICAL OUTCOME, International journal of radiation oncology, biology, physics, 39(3), 1997, pp. 579-587
Authors:
ELIAS AD
SKARIN AT
LEONG T
MENTZER S
STRAUSS G
LYNCH T
SHULMAN L
JACOBS C
ABNER A
BALDINI EH
FREI E
SUGARBAKER DJ
Citation: Ad. Elias et al., NEOADJUVANT THERAPY FOR SURGICALLY STAGED IIIA N2 NONSMALL CELL LUNG-CANCER (NSCLC), Lung cancer, 17(1), 1997, pp. 147-161
Authors:
STRAUSS GM
LYNCH TJ
ELIAS AD
JACOBS C
HERBST R
LEONG T
LYNCH C
KWIATKOWSKI DJ
CAREY RW
GROSSBARD ML
SKARIN AT
Citation: Gm. Strauss et al., IFOSFAMIDE CARBOPLATIN/ETOPOSIDE/PACLITAXEL IN ADVANCED LUNG-CANCER -UPDATE AND PRELIMINARY SURVIVAL ANALYSIS/, Seminars in oncology, 24(4), 1997, pp. 73-80
Authors:
GREIPP PR
LEONG T
KAY NE
VANNESS BG
OKEN MM
KYLE RA
Citation: Pr. Greipp et al., FROM ECOG MYELOMA TRIAL E9486 - A PROGNOSTIC INDEX BASED ON TUMOR BURDEN, PROLIFERATION AND HOST IMMUNE STATUS, Blood, 90(10), 1997, pp. 1561-1561
Authors:
KAY NE
BONE N
LEONG T
OKEN MM
KYLE RA
VANNESS B
GREIPP PR
Citation: Ne. Kay et al., SEQUENTIAL PHENOTYPIC ANALYSIS OF BLOOD IMMUNE CELLS IN MYELOMA PATIENTS TREATED ON ECOG PROTOCOL E9486 - RELATIONSHIP OF IMMUNE CELLS TO TREATMENT AND CLINICAL OUTCOME, Blood, 90(10), 1997, pp. 1595-1595
Authors:
KAY NE
LEONG T
KYLE RA
GREIPP P
BILLADEAU D
VANNESS B
BONE N
OKEN MM
Citation: Ne. Kay et al., CIRCULATING BLOOD B-CELLS IN MULTIPLE-MYELOMA - ANALYSIS AND RELATIONSHIP TO CIRCULATING CLONAL CELLS AND CLINICAL-PARAMETERS IN A COHORT OF PATIENTS ENTERED ON THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-IIIE9486 CLINICAL-TRIAL, Blood, 90(1), 1997, pp. 340-345
Authors:
LEONG T
GUINEY M
NGAN S
MACKAY J
Citation: T. Leong et al., PREOPERATIVE RADIOTHERAPY AND CHEMOTHERAPY FOR NONRESECTABLE RECTAL-CANCER, Australian and New Zealand journal of surgery, 67(9), 1997, pp. 603-606
Authors:
MORGAN G
LEONG T
BERG D
Citation: G. Morgan et al., MANAGEMENT OF SEMINOMA OF THE TESTIS - RECOMMENDATIONS BASED ON TREATMENT RESULTS, Australian and New Zealand journal of surgery, 67(1), 1997, pp. 15-20
Authors:
MAZZA JJ
LEONG T
ROWE JM
WIERNIK PH
CASSILETH PA
Citation: Jj. Mazza et al., TREATMENT OF ADULT PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA IN RELAPSE, Leukemia & lymphoma, 20(3-4), 1996, pp. 317-319
Authors:
OZCAN S
LEONG T
JOHNSTON M
Citation: S. Ozcan et al., RGT1P OF SACCHAROMYCES-CEREVISIAE, A KEY REGULATOR OF GLUCOSE-INDUCEDGENES, IS BOTH AN ACTIVATOR AND A REPRESSOR OF TRANSCRIPTION, Molecular and cellular biology, 16(11), 1996, pp. 6419-6426
Authors:
JANOV AJ
LEONG T
NATHAN DG
GUINAN EC
Citation: Aj. Janov et al., DIAMOND-BLACKFAN ANEMIA - NATURAL-HISTORY AND SEQUELAE OF TREATMENT, Medicine, 75(2), 1996, pp. 77-87
Authors:
LIU PC
LEONG T
QUAM L
BILLADEAU D
KAY NE
GREIPP P
KYLE RA
OKEN MM
VANNESS B
Citation: Pc. Liu et al., ACTIVATING MUTATIONS OF N-RAS AND K-RAS IN MULTIPLE-MYELOMA SHOW DIFFERENT CLINICAL ASSOCIATIONS - ANALYSIS OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-III TRIAL, Blood, 88(7), 1996, pp. 2699-2706
Authors:
TRENDLE MC
LEONG T
KYLE RA
OKEN MM
KAY NE
VANNESS B
GREIPP PR
Citation: Mc. Trendle et al., HYPODIPLOID MYELOMA REVISITED - RESPONSE TO THERAPY AND SURVIVAL IN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY E9486, Blood, 88(10), 1996, pp. 1549-1549
Authors:
KAY NE
BONE N
LEONG T
OKEN MM
KYLE RA
VANNESS B
GREIPP PR
Citation: Ne. Kay et al., T-HELPER PHENOTYPES IN THE BLOOD OF MYELOMA PATIENTS - ANALYSIS BY TREATMENT STATUS AND WITH CLINICAL-PARAMETERS, Blood, 88(10), 1996, pp. 1557-1557
Authors:
KAY NE
OKEN MM
KYLE R
VANNESS B
KALISH L
LEONG T
GREIPP P
Citation: Ne. Kay et al., SEQUENTIAL PHENOTYPING OF MYELOMA PATIENTS ON CHEMOTHERAPY - PERSISTENCE OF ACTIVATED T-CELLS AND NATURAL-KILLER-CELLS, Leukemia & lymphoma, 16(3-4), 1995, pp. 351-354
Authors:
DUTCHER JP
LEONG T
MAKARY AZ
BENNETT J
FRONTIERA M
MILLER H
WIERNIK PH
Citation: Jp. Dutcher et al., A PHASE-II STUDY OF MENOGARIL (7R-O-METHYLNOGAROL) IN PATIENTS WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP/, Leukemia, 9(10), 1995, pp. 1638-1642
Authors:
WITTE RS
LEONG T
ERNSTOFF MS
KRIGEL RL
OKEN MM
HARRIS J
TORMEY DC
TRUMP DL
Citation: Rs. Witte et al., A PHASE-II STUDY OF INTERLEUKIN-2 WITH AND WITHOUT INTERFERON-BETA INTHE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA, Investigational new drugs, 13(3), 1995, pp. 241-247
Authors:
SALAZAR M
LEONG T
TU N
GELMAN RS
WATSON ALM
BRONSON R
IGLESIAS A
MANN M
GOOD RA
YUNIS EJ
Citation: M. Salazar et al., LIFE-SPAN, T-CELL RESPONSES, AND INCIDENCE OF LYMPHOMAS IN CONGENIC MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(9), 1995, pp. 3992-3996
Authors:
MILLER H
LEONG T
KHANDEKAR J
GREIPP P
KYLE R
KRAM J
Citation: H. Miller et al., PACLITAXEL AS THE INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM) AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) STUDY, Blood, 86(10), 1995, pp. 738-738
Authors:
KAY N
LEONG T
VANNESS B
OKEN M
GREIPP P
BONE N
BILLADEAU D
KYLE R
Citation: N. Kay et al., CIRCULATING CD19-CELLS IN MULTIPLE-MYELOMA - PHENOTYPIC AND MOLECULARANALYSIS OF ECOG TRIAL E9486( BLOOD)9487/, Blood, 86(10), 1995, pp. 1088-1088
Authors:
OKEN MM
LEONG T
KAY NE
GREIPP PR
VANNESS B
KYLE RA
Citation: Mm. Oken et al., THE EFFECT OF ADDING INTERFERON (RIFN(ALPHA-2)) OR HIGH-DOSE CYCLOPHOSPHAMIDE TO VBMCP TO TREAT MULTIPLE-MYELOMA - RESULTS FROM AN ECOG PHASE-III TRIAL, Blood, 86(10), 1995, pp. 1749-1749
Authors:
VANNESS B
LEONG T
QUAM L
LIU P
BILLADEAU D
KAY N
OKEN MM
GREIPP P
KYLE R
Citation: B. Vanness et al., DISTINCT RAS MUTATIONS IN MULTIPLE-MYELOMA (MM) CORRELATE WITH TUMOR BURDEN AND SURVIVAL - ANALYSIS OF ECOG PHASE-III TRIAL, Blood, 86(10), 1995, pp. 1755-1755
Authors:
KAY NE
OKEN MM
BONE N
KYLE RA
GREIPP P
VANNESS B
LEONG T
Citation: Ne. Kay et al., CIRCULATING CD19(-CELL LEVELS IN MYELOMA() BLOOD), Blood, 86(10), 1995, pp. 4000-4000